Our companiesin action
Our diverse portfolio features disruptive biotech ventures with exceptional teams and innovative science.
Our diverse portfolio features disruptive biotech ventures with exceptional teams and innovative science.
Denmark
Spain
The Netherlands
Spain
(NASDAQ: AURA)
USA
USA
(Acq. Amgen)
USA
France
(NASDAQ: CVRX)
USA
Denmark
(Acq. St Jude Medical/Abbott)
Switzerland
(NASDAQ: GLTO)
Denmark
Spain
(NASDAQ: KALA)
USA
(NASDAQ: LVTX)
The Netherlands
Spain
(NASDAQ: MLYS)
USA
Spain
The Netherlands
Spain
Sweden
(Acq. Lundbeck)
Switzerland
(Acq. Vifor Pharma)
Spain
France
Spain
(Acq. Qiagen)
Spain
Switzerland
(Acq. Takeda Pharmaceuticals)
Spain
The Netherlands
France/Spain
Switzerland/The Netherlands